long half-life and large variability [Regulatives / Guidelines]

posted by martin  – Austria, 2020-07-29 18:57 (919 d 19:48 ago) – Posting: # 21798
Views: 2,668

Dear all,

I would appreciate the forum members thoughts on the following situation.

In short:My interpretation of regulatoy guidelines: adding additional fixed effect factors to the factors mentioned in the guidelines is typically considered as not acceptable by regulators.

best regards & looking forward to some ideas to potentially address this situation

martin

Complete thread:

UA Flag
Activity
 Admin contact
22,478 posts in 4,708 threads, 1,603 registered users;
11 visitors (0 registered, 11 guests [including 10 identified bots]).
Forum time: 13:45 CET (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5